DGAP-DD: Biotest AG english

        Print
| Source: EQS Group AG

Notification concerning transactions by persons performing managerial
responsibilities pursuant to section 15a of the WpHG

Directors' Dealings notification transmitted by DGAP – a service of EQS Group
AG. 
The person with duty of notification is solely responsible for the content
of this announcement.
---------------------------------------------------------------------------

Details of the person subject to the disclosure requirement
Last name: Prof. Dr. Rothenburger
First name: Markus
Company: Biotest AG

Position: Division Head of Medical/Regulatory Affairs

Information about the transaction with duty of notification

Description of the financial instrument: Preference Shares
ISIN/WKN of the financial instrument: DE0005227235
Type of transaction: Purchase
Date: 12.08.2014
Price: 70.10
Currency: EUR
No. of items: 400
Total amount traded: 28040
Place: Stuttgart

Information about the company with duty of publication

Issuer: Biotest AG
Landsteinerstraße 5
63303 Dreieich
Deutschland
ISIN: DE0005227235
WKN: 522723


End of Directors' Dealings Notification 
(c) DGAP 12.08.2014

DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

ID 19303